Small Molecules

02 Jun 2007 Thallion announces publication of eco-4601 phase I/II Clinical data at ASCO
02 Jun 2007 ZIO-101 Oral Capsule Clears FDA Review for Phase I Study
02 Jun 2007 Arrowhead subsidiary, Insert, publishes interim Phase I data from human clinical trials for new cancer drug
02 Jun 2007 Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
02 Jun 2007 OXiGENE Abstracts Published in ASCO Program
01 Jun 2007 AtheroGenics Announces Business Plan to Focus on Advancing AGI-1067 in Diabetes
01 Jun 2007 LifeCycle Pharma Announces Positive Phase I Clinical Results
01 Jun 2007 Skyepharma PLC - Twice daily ZYFLO CR(TM) (zileuton) extended-release tablets approved by the FDA for asthma
01 Jun 2007 New research confirms the benefit of extended-release dipyridamole plus ASA for preventing recurrent stroke in low- and high-risk patients
01 Jun 2007 Progenics and Wyeth Announce FDA Has Accepted For Filing the New Drug Application for Subcutaneous Methylnaltrexone
01 Jun 2007 AVANIR Receives FDA Approval for New Formulation of Currently Marketed Antipsychotic Drug FazaClo
01 Jun 2007 ISTA Pharmaceuticals Announces Positive Preliminary Results from Ecabet Sodium Phase IIb Study
01 Jun 2007 Labopharm Receives Second Approvable Letter from FDA for Once-Daily Tramadol
01 Jun 2007 Allos Therapeutics Initiates Phase I/II Study of PDX and Gemcitabine in Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
01 Jun 2007 Valeant Pharmaceuticals to Initiate Study of Retigabine for Pain Associated with Post-Herpetic Neuralgia
31 May 2007 Exelixis Initiates Phase II Trial of XL647 in NSCLC Patients Who Have Previously Benefited From EGFR Inhibitors or Have the T790M Mutant Form of EGFR
31 May 2007 Novacea and Schering-Plough Enter into Worldwide Development and Commercialization Agreement for Asentar, a Novel Treatment for Prostate Cancer
31 May 2007 TopoTarget has received an approvable letter for Totect
31 May 2007 Mersana Therapeutics, Inc. Initiates Phase I Trial of Anti-Cancer Agent, XMT-1001, in Solid Tumors
31 May 2007 Celsion Completes Enrollment in Phase I Liver Cancer Study
31 May 2007 Antares and the Population Council Initiate Phase I Clinical Study with Innovative Low-Dose Contraceptive
31 May 2007 FDA Approves TORISEL, a Targeted First-in-Class mTOR Inhibitor for the Treatment of Advanced Kidney Cancer
31 May 2007 Data Published in the New England Journal of Medicine Showed TORISEL Extended Median Overall Survival for Patients with Advanced Renal Cell Carcinoma
31 May 2007 Theravance Announces Acceptance of Telavancin MAA for the Treatment of Complicated Skin and Soft Tissue Infections in Europe
31 May 2007 CeNeRx BioPharma, Inc. Announces Agreement With PharmaNess Neuroscience to Develop Novel Cannabinoid Compounds

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing